Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald D Perrone

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Kidney International Reports|January 10, 2022
<i>PKD1</i> Compared With <i>PK</i> <i>D2</i> Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease StudiesCortney Steele, Zhiying You, Berenice Y Gitomer, et al.
Current Hypertension Reviews|May 3, 2017
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Frederic F Rahbari-Oskoui, et al.
Kidney International|September 24, 2017
Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceSégolène Aymé, Detlef Bockenhauer, Simon Day, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2013
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional studyDana C Miskulin, Kaleab Z Abebe, Arlene B Chapman, et al.
Journal of the American Society of Nephrology : JASN|June 4, 2020
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney DiseaseKyongtae T Bae, Tiange Shi, Cheng Tao, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 16, 2020
Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic ReviewBénédicte Sautenet, Yeoungjee Cho, Talia Gutman, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2019
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical SimulationTom Greene, Jian Ying, Edward F Vonesh, et al.
Current Hypertension Reviews|March 23, 2018
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?Godela M Brosnahan, Kaleab Z Abebe, Charity G Moore, et al.
Journal of the American Society of Nephrology : JASN|November 10, 2017
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney DiseaseKristen L Nowak, Zhiying You, Berenice Gitomer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2022
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney DiseaseKyongtae T Bae, Cheng Tao, Robert Feldman, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Kidney International Reports|January 10, 2022
<i>PKD1</i> Compared With <i>PK</i> <i>D2</i> Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease StudiesCortney Steele, Zhiying You, Berenice Y Gitomer, et al.
Current Hypertension Reviews|May 3, 2017
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Frederic F Rahbari-Oskoui, et al.
Kidney International|September 24, 2017
Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceSégolène Aymé, Detlef Bockenhauer, Simon Day, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2013
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional studyDana C Miskulin, Kaleab Z Abebe, Arlene B Chapman, et al.
Journal of the American Society of Nephrology : JASN|June 4, 2020
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney DiseaseKyongtae T Bae, Tiange Shi, Cheng Tao, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 16, 2020
Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic ReviewBénédicte Sautenet, Yeoungjee Cho, Talia Gutman, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2019
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical SimulationTom Greene, Jian Ying, Edward F Vonesh, et al.
Current Hypertension Reviews|March 23, 2018
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?Godela M Brosnahan, Kaleab Z Abebe, Charity G Moore, et al.
Journal of the American Society of Nephrology : JASN|November 10, 2017
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney DiseaseKristen L Nowak, Zhiying You, Berenice Gitomer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2022
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney DiseaseKyongtae T Bae, Cheng Tao, Robert Feldman, et al.
Pageof 13